Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Zhang, Shuhong ^a   Li, Jianfeng ^a   Jiang, Ying ^a   Xu, Yijun ^a   Qin, Chengyong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIGEL; TUMOR ANTIGEN; APOPTOSIS REGULATORY PROTEIN; HISTONE DEACETYLASE; MTA1 PROTEIN, HUMAN; PDCD4 PROTEIN, HUMAN; REPRESSOR PROTEIN; RNA BINDING PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOMA CELL; CELL DEATH; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROGRAMMED CELL DEATH 4 GENE; TUMOR SUPPRESSOR GENE; ANIMAL; CELL ADHESION; CELL CYCLE; CELL MOTION; CELL STRAIN 3T3; FLOW CYTOMETRY; GENETICS; LIVER TUMOR; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; HISTONE DEACETYLASES; HUMANS; LIVER NEOPLASMS; MICE; NIH 3T3 CELLS; REPRESSOR PROTEINS; RNA-BINDING PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 68149092544     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-71     Document Type: Article

References (35)

1. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia. West Africa. GD Kirk E Bah R Montesano, Carcinogenesis 2006 27 2070 2082 10.1093/carcin/bgl060 16679307 (Pubitemid 44530582)
2. Spontaneous Rupture of Hepatocellular Carcinoma: A Systematic Review. EC Lai WY Lau, Arch Surg 2006 141 191 198 10.1001/archsurg.141.2.191 16490898 (Pubitemid 43276572)
3. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. X Li Y Pan R Fan H Jin S Han J Liu K Wu D Fan, Carcinogenesis 2008 29 1587 1593 18299278 10.1093/carcin/bgn052
4. Staging and Current Treatment of Hepatocellular Carcinoma. HP Clark WF Carson PV Kavanagh CP Ho P Shen RJ Zagoria, Radiographics 2005 25 S3 23 10.1148/rg.25si055507 16227495 (Pubitemid 41686059)
5. Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be? AX Zhu, Oncologist 2006 11 790 800 10.1634/theoncologist.11-7-790 16880238 (Pubitemid 44157567)
6. Colburn NH. Differentially expressed protein PDCD4 inhibits tumor promoter-induced neoplastic transformation. JL Cmarik H Min G Hegamyer S Zhan M Kulesz-Martin H Yoshinaga S Matsuhashi, Proc Natl Acad Sci USA 1999 96 14037 14042 10570194 10.1073/pnas.96.24.14037
7. Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4. Nicole LaRonde-LeBlanc Arti N Santhanam Alyson R Baker Alexander Wlodawer Nancy H Colburn, Mol Cell Biol 2007 27 147 156 17060447 10.1128/MCB.00867-06 (Pubitemid 46013240)
8. Tumorigenesis Suppressor PDCD4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion. HS Yang CP Matthews T Clair Q Wang AR Baker CC Li TH Tan NH Colburn, Mol Cell Biol 2006 26 1297 1306 16449643 10.1128/MCB.26.4.1297-1306.2006 (Pubitemid 43202557)
9. MAP kinases and cell migration. C Huang K Jacobson MD Schaller, J Cell Sci 2004 117 4619 4628 10.1242/jcs.01481 15371522 (Pubitemid 39433429)
10. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. Y Toh SD Pencil GL Nicolson, J Biol Chem 1994 269 22958 22963 8083195
11. Metastasis Tumor Antigen Family Proteins during Breast Cancer Progression and Metastasis in a Reliable Mouse Model for Human Breast Cancer. H Zhang LC Stephens R Kumar, Clin Cancer Res 2006 12 1479 1486 10.1158/1078-0432.CCR-05- 1519 16533771
12. The Role of Metastasis-Associated Protein 1 in Prostate Cancer Progression. MD Hofer R Kuefer S Varambally H Li J Ma GI Shapiro JE Gschwend RE Hautmann MG Sanda K Giehl A Menke AM Chinnaiyan MA Rubin, Cancer Res 2004 64 825 829 10.1158/0008-5472.CAN-03-2755 14871807 (Pubitemid 38176879)
13. GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for real-time PCR. M Kidd B Nadler S Mane G Eick M Malfertheiner M Champaneria R Pfragner I Modlin, Physiol Genomics 2007 30 363 370 10.1152/physiolgenomics. 00251.2006 17456737 (Pubitemid 47296195)
14. FTY720: A Promising Agent for Treatment of Metastatic Hepatocellular Carcinoma. TK Lee K Man JW Ho XH Wang RT Poon Y Xu KT Ng AC Chu CK Sun IO Ng HC Sun ZY Tang R Xu ST Fan, Clin Cancer Res 2005 11 8458 8466 10.1158/1078-0432. CCR-05-0447 16322309 (Pubitemid 41746961)
15. CABYR Is a Novel Cancer-Testis Antigen in Lung Cancer. C Luo X Xiao D Liu S Chen M Li A Xu J Liu S Gao S Wu D He, Clin Cancer Res 2007 13 1288 1297 10.1158/1078-0432.CCR-06-1742 17317841 (Pubitemid 46424070)
16. Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis. RB Hazan GR Phillips RF Qiao L Norton SA Aaronson, J Cell Biol 2000 148 779 790 10684258 10.1083/jcb.148.4.779 (Pubitemid 30679693)
17. Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis. C Röcken R Kientsch-Engel S Mansfeld B Stix K Stubenrauch B Weigle F Bühling M Schwan W Saeger, Am J Pathol 2003 162 1213 1220 12651613
18. Independent Association of Angiogenesis Index with Outcome in Prostate Cancer. R Mehta A Kyshtoobayeva T Kurosaki EJ Small H Kim R Stroup CE McLaren KT Li JP Fruehauf, Clin Cancer Res 2001 7 81 88 11205922
19. -CTmethod. KJ Livak TD Schmittgen, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
20. NGEP, a Prostate-Specific Plasma Membrane Protein that Promotes the Association of LNCaP Cells. S Das Y Hahn S Nagata MC Willingham TK Bera B Lee I Pastan, Cancer Res 2007 67 1594 1601 10.1158/0008-5472.CAN-06-2673 17308099 (Pubitemid 46383384)
21. Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. N Li F Yi CM Sundy L Chen ML Hilliker DK Donley DB Muldoon PL Li, Am J Physiol Renal Physiol 2007 292 F207 F216 10.1152/ajprenal.00457.2005 16885149 (Pubitemid 46105261)
22. Estrogens Up-Regulate the Fas/FasL Apoptotic Pathway in Lactotropes. G Jaita M Candolfi V Zaldivar S Zárate L Ferrari D Pisera MG Castro A Seilicovich, Endocrinology 2005 146 11 4737 44 16099864 10.1210/en.2005-0279 (Pubitemid 41446611)
23. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin. H Hu Y Shikama I Matsuoka J Kimura, J Leukoc Biol 2008 83 2 393 400 10.1189/jlb.0507282 17965335 (Pubitemid 351225620)
24. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. J Liang Y Pan D Zhang C Guo Y Shi J Wang Y Chen X Wang J Liu X Guo Z Chen T Qiao D Fan, FASEB J 2007 21 9 2247 56 10.1096/fj.06-7799com 17409275 (Pubitemid 47026459)
25. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. D Sareen PR van Ginkel JC Takach A Mohiuddin SR Darjatmoko DM Albert AS Polans, Invest Ophthalmol Vis Sci 2006 47 9 3708 16 10.1167/iovs.06-0119 16936077 (Pubitemid 46049513)
26. Cloning of a Novel Apaf-1-Interacting Protein: a Potent Suppressor of Apoptosis and Ischemic Neuronal Cell Death. G Cao M Xiao F Sun X Xiao W Pei J Li SH Graham RP Simon J Chen, J Neurosci 2004 24 6189 6201 10.1523/JNEUROSCI.1426- 04.2004 15240811 (Pubitemid 38891110)
27. Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells. N Ishimura H Isomoto SF Bronk GJ Gores, Am J Physiol Gastrointest Liver Physiol 2006 290 G129 G136 10.1152/ajpgi.00242.2005 16166346
28. Loss of PDCD4 expression in human lung cancer correlates with tumor progression and prognosis. Y Chen T Knösel G Kristiansen A Pietas ME Garber S Matsuhashi I Ozaki I Petersen, J Pathol 2003 200 640 646 10.1002/path.1378 12898601 (Pubitemid 36987314)
29. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. L Azzoni O Zatsepina B Abebe IM Bennett P Kanakaraj B Perussia, J Immunol 1998 161 7 3493 500 9759869
30. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. H Zhang I Ozaki T Mizuta H Hamajima T Yasutake Y Eguchi H Ideguchi K Yamamoto S Matsuhashi, Oncogene 2006 25 45 6101 12 10.1038/sj.onc.1209634 16682950 (Pubitemid 44562408)
31. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21 (Waf1/Cip1). R Göke P Barth A Schmidt B Samans B Lankat-Buttgereit, Am J Physiol Cell Physiol 2004 287 C1541 C1546 10.1152/ajpcell.00025.2004 15317660 (Pubitemid 39507671)
32. The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. EW Verschuren N Jones GI Evan, J Gen Virol 2004 85 Pt 6 1347 61 10.1099/vir.0.79812-0 15166416 (Pubitemid 38807731)
33. Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid-Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia. B Ozpolat U Akar M Steiner I Zorrilla-Calancha M Tirado-Gomez N Colburn M Danilenko S Kornblau GL Berestein, Mol Cancer Res 2007 5 95 108 10.1158/1541-7786.MCR-06-0125 17259349 (Pubitemid 46246770)
34. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. XY Zhang LM DeSalle JH Patel AJ Capobianco D Yu A Thomas-Tikhonenko SB McMahon, Proc Natl Acad Sci USA 2005 102 13968 13973 16172399 10.1073/pnas.0502330102 (Pubitemid 41377687)
35. Downregulated AP-1 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells. G Stapleton A Malliri BW Ozanne, J Cell Sci 2002 115 2713 2724 12077362